Skip to content
Lower risk Medical device recall · FDA · Published December 23, 2022

Philips Incisive CT Software 5.0.0 Recall: Misdiagnosis Risk from Image Artifacts

Philips Healthcare recalls Incisive CT models 728143 & 728144 with software version 5.0.0 due to potential misdiagnosis from image artifacts and incorrect labels. Affected units may require rescan or correction.

🇺🇸 FDA recall #Z-0640-2024Medical devicePhilips Healthcare ›
Take action

Contact the company

Recalling firmPhilips Healthcare (Suzhou) Co., Ltd.Suzhou Industrial Park, No. 258 Zhongyuan Road; Pingjiang · Suzhou, China
✎ GovInfoNow plain-language explainer

Philips Healthcare is recalling two specific CT scanner models with software version 5.0.0 because software issues could cause misdiagnosis through image artifacts or incorrect labels. This affects medical imaging accuracy and may require additional scans. Read more at govinfonow.com/recall/59054-philips-incisive-ct-software-5-0-0-recall-misdiagnosis-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/59054-philips-incisive-ct-software-5-0-0-recall-misdiagnosis-risk · Updated August 19, 2026 · FDA enforcement record: FDA #Z-0640-2024

Cite this page

“Philips Incisive CT Software 5.0.0 Recall: Misdiagnosis Risk from Image Artifacts.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/59054-philips-incisive-ct-software-5-0-0-recall-misdiagnosis-risk. Based on FDA recall #Z-0640-2024 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0640-2024%22&limit=1).

The FDA announced on 2022-12-23 that Philips Healthcare (Suzhou) Co., Ltd. is recalling Incisive CT units, models 728143 and 728144 running Software Version 5.0.0. The agency cited multiple software issues that could lead to misdiagnosis due to image artifacts or incorrect orientation labels.

How to tell if you have it

  • Philips Healthcare Incisive CT, models 728143 and 728144
  • Software Version 5.0.0
  • UDI-DI: 00884838085015 (Model 728143)
  • UDI-DI: 00884838105508 (Model 728144)

The hazard

According to the FDA, the recall addresses software issues that may cause image artifacts, reversed orientation labels in 2D images, or the need for a CT rescan. Other reported defects include non-functional auto voice during cardiac scans, quiet audio levels, incomplete image reconstruction, and couch motion signal errors.

Context

GovInfoNow's records show Philips Healthcare (Suzhou) Co., Ltd. has issued three other recalls since 2021-02-24. Recent similar recalls include the 2026-06-26 Philips Incisive CT Software V4.5/V5.0 Recall for potential bolus tracking failure, the 2025-12-03 Philips Incisive Recall regarding unstable sensors causing incomplete scans, and the 2021-02-24 Philips CT Systems Recall where the couch may fail to lock. Other recent recalls of similar products include the 2026-08-07 Philips Ingenuity CT Scanners recall for unintended radiation risk, the 2026-08-07 Philips Brilliance CT Scanners recall for unintended radiation risk in Software 4.1.10.x, and the 2026-08-07 Philips IQon Spectral CT Software 4.7.7.x Recall for unintended radiation risk.

How to tell if you have this one

Check if your Philips Incisive CT scanner has model numbers 728143 or 728144 and software version 5.0.0. The unique device identifiers (UDI-DI) are 00884838085015 for model 728143 and 00884838105508 for model 728144.

  • Brand
    Philips Healthcare
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Software Version

    Verify your scanner's software version by checking the device settings or documentation. If it is version 5.0.0, it is affected.

Where it went and when

Where it was distributed

Distributed nationwide and abroad; the notice names 36 states.

Alaska: nationwideAKMaine: named in the noticeMEVermont: named in the noticeVTNew Hampshire: nationwideNHWashington: nationwideWAIdaho: named in the noticeIDMontana: nationwideMTNorth Dakota: named in the noticeNDMinnesota: nationwideMNIllinois: named in the noticeILWisconsin: named in the noticeWIMichigan: named in the noticeMINew York: named in the noticeNYRhode Island: named in the noticeRIMassachusetts: nationwideMAOregon: nationwideORNevada: nationwideNVWyoming: nationwideWYSouth Dakota: nationwideSDIowa: nationwideIAIndiana: named in the noticeINOhio: named in the noticeOHPennsylvania: named in the noticePANew Jersey: named in the noticeNJConnecticut: named in the noticeCTCalifornia: named in the noticeCAUtah: named in the noticeUTColorado: named in the noticeCONebraska: named in the noticeNEMissouri: named in the noticeMOKentucky: named in the noticeKYWest Virginia: nationwideWVVirginia: nationwideVAMaryland: named in the noticeMDDelaware: nationwideDEArizona: named in the noticeAZNew Mexico: named in the noticeNMKansas: named in the noticeKSArkansas: named in the noticeARTennessee: named in the noticeTNNorth Carolina: named in the noticeNCSouth Carolina: named in the noticeSCDistrict of Columbia: nationwideDCOklahoma: named in the noticeOKLouisiana: named in the noticeLAMississippi: named in the noticeMSAlabama: named in the noticeALGeorgia: named in the noticeGAHawaii: named in the noticeHITexas: named in the noticeTXFlorida: named in the noticeFLPuerto Rico: named in the noticePR

FDA distribution: “Worldwide - US Nationwide distribution including in the states of AL, AR, AZ, CA, CO, CT, FL, GA, HI, ID, IL, IN, KS, KY, LA, MD, ME, MI, MO, MS, NC, ND, NE, NJ, NM, NY, OH, OK, PA, RI, SC, TN, TX, UT, VT, WI, & Puerto Rico and the…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Kansas, Kentucky, Louisiana, Maine, Maryland, Michigan, Mississippi, Missouri, Nebraska, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, Tennessee, Texas, Utah, Vermont, Wisconsin.

Recall timeline

FDA published this recall 13 months after the firm started it.

1. Firm started the recall: Dec 23, 202212. FDA classified it Class II: Jan 5, 202423. Published in FDA’s Enforcement Report: Jan 17, 2024320222024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Are there any immediate safety risks?

No immediate physical risks are reported; the issue relates to potential misdiagnosis, not direct harm to users.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0640-2024 (December 23, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0640-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA